Short answer · Medically reviewed summary · Last updated: 2026-05-08
Macular degeneration, primarily age-related macular degeneration (AMD), is caused by a complex interplay of genetic predisposition, environmental influences, and progressive metabolic changes in the retinal pigment epithelium. While the exact trigger remains a subject of intense research, the condition is fundamentally driven by the accumulation of cellular waste products and chronic inflammation that damages the macula, the part of the eye responsible for sharp central vision. What are the primary causes and risk factors of macular degeneration? It is important to distinguish between "causes"—the biological mechanisms leading to cellular death—and "risk factors," which are external or internal conditions that increase the likelihood of developing macular degeneration.
Macular degeneration, primarily age-related macular degeneration (AMD), is caused by a complex interplay of genetic predisposition, environmental influences, and progressive metabolic changes in the retinal pigment epithelium. While the exact trigger remains a subject of intense research, the condition is fundamentally driven by the accumulation of cellular waste products and chronic inflammation that damages the macula, the part of the eye responsible for sharp central vision.
It is important to distinguish between "causes"—the biological mechanisms leading to cellular death—and "risk factors," which are external or internal conditions that increase the likelihood of developing macular degeneration. The primary mechanism involves the failure of the eye to clear debris called drusen, which triggers inflammatory pathways. Key risk factors include:
Macular degeneration has a strong genetic component, though it is not a simple Mendelian disorder (caused by a single gene). Instead, it is polygenic, meaning multiple gene variants work together to increase susceptibility. If you have a first-degree relative with macular degeneration, your own risk is approximately 3 to 4 times higher than the general population.
Researchers are currently investigating how the complement system—a part of our immune system—becomes overactive in the eyes of patients with macular degeneration. Think of the complement system as a "cleanup crew" that has become overzealous and started damaging healthy retinal cells instead of just removing debris. Current studies are focused on inhibiting these inflammatory pathways to stop the progression of both dry and wet forms of the disease.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.